← Leaderboards
Towfique Raj
Brigham And Women'S Hospital
$16,954,166
Attributed
$22,135,094
Total exposure
14
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.3M · FY2012–25$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,325,065 · 15
By mechanism
U54$9,806,332 · 3
R01$9,070,830 · 3
U01$6,297,545 · 2
RF1$2,360,820 · 1
R56$1,153,551 · 2
R21$1,064,102 · 2
Top collaborators
- Aaron D. Gitler6 shared
- David Arthur Knowles6 shared
- Leonard Petrucelli6 shared
- Mercedes Prudencio6 shared
- William W Seeley6 shared
- Pietro Fratta5 shared
- Kristen Jennifer Brennand3 shared
- Lotje Dorothee De Witte2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Thomas Glenn Travison$4,113,118
- Zhe Li$8,930,965
- William J Schroeder$3,945,722
- Bo Zhao$7,274,065
- Tanya N. Mayadas$28,624,599
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposGenesBrainGeneticGenetic VariantNeurodegenerative DisordersGenome Wide Association StudyS DiseasePathogenesisAffectMolecularCellsRna SplicingLinkInsightRisk VariantVariantGene ExpressionQuantitative Trait LociFunctional DisorderMicrogliaGenomicsData SetNew Therapeutic Target
Grant awards (39)
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,572,782
U54 · FY2025 · NS
Modeling the impact of regulatory and splicing variants on cellular function in Alzheimer's disease$772,791
R01 · FY2025 · AG · contact PI
The Role of Myeloid Cells in Parkinson's Disease$605,892
R01 · FY2025 · NS · contact PI
Genetic determinants of TF binding in pooled microglia$464,750
R21 · FY2025 · AG · contact PI
Genomics Core$324,349
U54 · FY2025 · NS · contact PI
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$53,900
U54 · FY2025 · NS
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,598,861
U54 · FY2024 · NS
Learning the Regulatory Code of Alzheimer's Disease Genomes$1,028,077
U01 · FY2024 · AG · contact PI
Modeling the impact of regulatory and splicing variants on cellular function in Alzheimer's disease$838,586
R01 · FY2024 · AG · contact PI
The Role of Myeloid Cells in Parkinson's Disease$657,644
R01 · FY2024 · NS · contact PI
Unraveling the Role of Clonal Hematopoiesis in Neurodegenerative Diseases$350,001
R56 · FY2024 · AG · contact PI
Genomics Core$321,166
U54 · FY2024 · NS · contact PI
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,597,452
U54 · FY2023 · NS
Learning the Regulatory Code of Alzheimer's Disease Genomes$1,105,599
U01 · FY2023 · AG · contact PI
The Role of Myeloid Cells in Parkinson's Disease$688,959
R01 · FY2023 · NS · contact PI
Genetics and Genomics Core$484,286
P30 · FY2023 · AG · contact PI
Genomics Core$307,042
U54 · FY2023 · NS · contact PI
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,644,973
U54 · FY2022 · NS
Learning the Regulatory Code of Alzheimer's Disease Genomes$1,133,201
U01 · FY2022 · AG · contact PI
The Role of Myeloid Cells in Parkinson's Disease$697,234
R01 · FY2022 · NS · contact PI
Genomics Core$324,430
U54 · FY2022 · NS · contact PI
Modeling the impact of regulatory and splicing variants on cellular function in Alzheimer's disease$2,360,820
RF1 · FY2021 · AG · contact PI
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,722,003
U54 · FY2021 · NS
Learning the Regulatory Code of Alzheimer's Disease Genomes$1,094,724
U01 · FY2021 · AG · contact PI
The role of peripheral myeloid cells in Alzheimers disease$825,123
R01 · FY2021 · AG · contact PI
The Role of Myeloid Cells in Parkinson's Disease$661,511
R01 · FY2021 · NS · contact PI
Genomics Core$339,374
U54 · FY2021 · NS · contact PI
Learning the Regulatory Code of Alzheimer's Disease Genomes$289,006
U01 · FY2021 · AG · contact PI
Learning the Regulatory Code of Alzheimer's Disease Genomes$1,139,701
U01 · FY2020 · AG · contact PI
The role of peripheral myeloid cells in Alzheimers disease$825,123
R01 · FY2020 · AG · contact PI
Identifying genetic and transcriptomic drivers of Parkinson's disease progression$507,237
U01 · FY2020 · NS · contact PI
The impact of Alzheimer's disease susceptibility alleles on microglia transcriptome$466,125
R21 · FY2020 · AG · contact PI
The impact of Alzheimer's disease susceptibility alleles on microglia transcriptome$133,227
R21 · FY2020 · AG · contact PI
The role of peripheral myeloid cells in Alzheimers disease$830,565
R01 · FY2019 · AG · contact PI
The Role of Alternative Splicing in Neurodegeneration$803,550
R56 · FY2019 · AG · contact PI
The role of peripheral myeloid cells in Alzheimers disease$833,701
R01 · FY2018 · AG · contact PI
The role of peripheral myeloid cells in Alzheimers disease$833,701
R01 · FY2017 · AG · contact PI
Exploring the Role of Transcriptome Variation in Cognitive Decline$35,409
F32 · FY2014 · AG · contact PI
Exploring the Role of Transcriptome Variation in Cognitive Decline$52,190
F32 · FY2012 · AG · contact PI